ScoreWhy is Wai Chun Bio-Technology Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -7.50% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 12.83 times
2
Flat results in Dec 24
- PRE-TAX PROFIT(Q) At HKD -11.2 MM has Fallen at -293.74%
- NET SALES(Q) Lowest at HKD 161.06 MM
- CASH AND EQV(HY) Lowest at HKD 1.78 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 256.16%, its profits have fallen by -88.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wai Chun Bio-Technology Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wai Chun Bio-Technology Ltd.
256.16%
0.88
122.29%
Hang Seng Hong Kong
18.06%
0.71
25.51%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.50%
EBIT Growth (5y)
-26.84%
EBIT to Interest (avg)
0.73
Debt to EBITDA (avg)
12.83
Net Debt to Equity (avg)
-1.56
Sales to Capital Employed (avg)
15.00
Tax Ratio
13.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.57%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.34
EV to EBIT
-17.81
EV to EBITDA
45.12
EV to Capital Employed
3.41
EV to Sales
0.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.14%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Wai Chun Bio-Technology Ltd.
Raw Material Cost
Fallen by -116.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At HKD 8.15 MM has Grown at 42.77%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Wai Chun Bio-Technology Ltd.
Pre-Tax Profit
At HKD -11.2 MM has Fallen at -293.74%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (HKD MM)
Net Sales
Lowest at HKD 161.06 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term sales trend is very negative
Net Sales (HKD MM)
Interest
Highest at HKD 10.37 MM
in the last five periods and Increased by 14.24% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Net Profit
Lowest at HKD -13.66 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Net Profit
Fallen at -102.87%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Cash and Eqv
Lowest at HKD 1.78 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -155.72 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
